Accelovance’s Stephen Trevisan And Robert deGroof On China’s Clinical Research Landscape: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
[Editor's Note: This is part two of a two-part interview. Part one appeared in PharmAsia News, May 15, 2008.]
You may also be interested in...
Chinese Health Care Reform: Market Opportunities And Challenges
China's renewed emphasis on reforming its health care system is creating both opportunities and challenges for foreign manufacturers doing business there, according to speakers at AdvaMed's 2008 MedTech Conference in Washington, D.C
Chinese Health Care Reform: Market Opportunities And Challenges
China's renewed emphasis on reforming its health care system is creating both opportunities and challenges for foreign manufacturers doing business there, according to speakers at AdvaMed's 2008 MedTech Conference in Washington, D.C
Lilly Sees Payoff In China By Boning Up On Tax And Patent Law
SAN FRANCISCO - Adept management of tax, patent and government relations issues particular to China can help Western pharmaceutical companies reap the benefits of working in the vast, developing market while avoiding pitfalls